KHPG(SZ:002773) Ge Long Hui A P P·2025-10-10 04:09Core Viewpoint - Kanghong Pharmaceutical (002773.SZ) has completed the absorption merger with Beijing Hongjian, which is expected to enhance operational efficiency, optimize resource allocation, and reduce management costs, aligning with the company's development strategy [1] Group 1: Merger Details - Beijing Hongjian has received the registration and cancellation approval from the Beijing Economic and Technological Development Zone Market Supervision Administration, confirming the completeness and legality of the cancellation application [1] - Following the merger, Beijing Kanghong Bio will continue to operate under the same name, shareholding structure, business scope, and registered capital [1] Group 2: Financial Impact - The financial statements of both the merging and merged entities have been included in the company's consolidated financial statements, indicating that the merger will not have a substantial impact on the consolidated financial reports [1] - The merger is not expected to adversely affect the company's overall business development and sustainable profitability, nor will it harm the interests of the company and its shareholders, particularly minority shareholders [1] Group 3: Ongoing Processes - As of now, Sichuan Jishengtang Xingshang Biotechnology Co., Ltd. and Beijing Hongjian have completed their cancellation processes, while Sichuan Kanghong Traditional Chinese Medicine Planting Co., Ltd. is in the process of merging with Chengdu Kanghong Pharmaceutical Trading Co., Ltd. [1]